ALGN:NASDAQAlign Technology, Inc. Analysis
Data as of 2026-05-13 - not real-time
$165.79
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Align Technology is trading at $165.79, just above its near‑term support of $162.72 and well below the $200.44 resistance. The 20‑day SMA (180.11) sits above price, while the 200‑day SMA (157.55) remains below, supporting a bullish bias despite a bearish MACD histogram and a sub‑50 RSI (38.8) that hints at potential upside. Volume is on a decreasing trend and the stock’s beta of 1.69, coupled with a 30‑day volatility of roughly 39%, signal heightened market‑risk exposure.
Fundamentally, ALGN delivered a 6.2% YoY revenue increase to $4.10 B, with strong gross (70%) and operating (16.6%) margins, and posted a non‑GAAP EPS beat at $2.58. The forward PE of 13.4 is well below the current PE of 27.9 and the industry average of 26.9, while the DCF fair value ($143.6) suggests the stock is modestly above intrinsic value, yet analyst consensus targets (~$209‑$214) imply ~26% upside. The company carries minimal debt, robust cash generation, and a “Buy” consensus from 14 analysts, reinforcing a growth‑oriented outlook.
Fundamentally, ALGN delivered a 6.2% YoY revenue increase to $4.10 B, with strong gross (70%) and operating (16.6%) margins, and posted a non‑GAAP EPS beat at $2.58. The forward PE of 13.4 is well below the current PE of 27.9 and the industry average of 26.9, while the DCF fair value ($143.6) suggests the stock is modestly above intrinsic value, yet analyst consensus targets (~$209‑$214) imply ~26% upside. The company carries minimal debt, robust cash generation, and a “Buy” consensus from 14 analysts, reinforcing a growth‑oriented outlook.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Recent earnings beat and positive guidance
- Price near support with bullish trend direction
- Technical oversold signal (RSI <40)
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Revenue growth and expanding margins
- Forward PE compression and analyst price targets indicating upside
- Strong cash flow and low leverage
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustained demand for digital orthodontic solutions
- Valuation modestly above DCF fair value
- Elevated beta and volatility implying market‑risk sensitivity
Key Metrics & Analysis
Financial Health
Revenue Growth6.20%
Profit Margin10.50%
P/E Ratio27.9
ROE10.82%
ROA7.33%
Debt/Equity2.80
P/B Ratio2.9
Op. Cash Flow$691.6M
Free Cash Flow$539.0M
Industry P/E26.9
Technical Analysis
TrendBullish
RSI38.8
Support$162.72
Resistance$200.44
MA 20$180.11
MA 50$176.57
MA 200$157.55
MACDBearish
VolumeDecreasing
Fear & Greed Index89.45
Valuation
Fair Value$143.62
Target Price$209.07
Upside/Downside26.11%
GradeFair
TypeGrowth
Risk Assessment
Beta1.69
Volatility39.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.